Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
CardioComm SolutionsEKGGF EV-to-EBIT is -3.51 as of Sep. 03, 2026. The stock has 8 warning signs investors should review. Among 477 Healthcare Providers & Services companies, CardioComm Solutions ranks worse than 209643.4% on this metric.
This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.
CardioComm Solutions's Enterprise Value for the quarter that ended in Dec. 2025 was $1.91 Mil.
CardioComm Solutions's EBIT for the trailing twelve months (TTM) ended in Dec. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.33 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
CardioComm Solutions EV-to-EBIT Related Terms
CardioComm Solutions EV-to-EBIT Historical Data
* Premium members only.
The historical data trend for CardioComm Solutions's EV-to-EBIT can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Health Information Services subindustry, CardioComm Solutions's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
CardioComm Solutions EV-to-EBIT vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, CardioComm Solutions's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where CardioComm Solutions's EV-to-EBIT falls into.
CardioComm Solutions's current Enterprise Value is $1.17 Mil.
CardioComm Solutions's EBIT for the trailing twelve months (TTM) ended in Dec. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.33 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
CardioComm Solutions (EKGGF) has a EV-to-EBIT of -3.51 as of Sep. 03, 2026. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on CardioComm Solutions and its competitors. According to the industry distribution chart, CardioComm Solutions ranks #999999 out of 477 companies in the Healthcare Providers & Services industry.
Is CardioComm Solutions' EV-to-EBIT too high?
CardioComm Solutions' current EV-to-EBIT is -3.51. Based on the distribution chart, CardioComm Solutions ranks #999999 out of 477 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers.
How does CardioComm Solutions' EV-to-EBIT compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, CardioComm Solutions ranks #999999 out of 477 companies for EV-to-EBIT. This places CardioComm Solutions in the lower half of its industry. The industry median EV-to-EBIT is 15.49. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBIT for a Healthcare Providers & Services company?
The median EV-to-EBIT among Healthcare Providers & Services companies is 15.49, based on 477 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBIT significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBIT mean?
A high EV-to-EBIT can signal that a stock is expensive relative to its fundamentals. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on CardioComm Solutions and its competitors. For the Healthcare Providers & Services industry, the median EV-to-EBIT is 15.49 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. CardioComm Solutions's current EV-to-EBIT is -3.51. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is CardioComm Solutions stock overvalued right now?
CardioComm Solutions (EKGGF) has a current EV-to-EBIT of -3.51. The current EV-to-EBIT is -3.51. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBIT calculated?
EV-to-EBIT is calculated from a company's financial statements. For CardioComm Solutions (EKGGF), the current EV-to-EBIT is -3.51 as of Sep. 03, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
CardioComm Solutions Inc develops software, hardware and core laboratory reading services related to electrocardiogram (ECG) and ambulatory arrhythmia monitoring systems for medical and consumer markets globally. The Company has one operating segment, which involves the development of software and the sale of ECG recording equipment and ECG reading services for the cardiology field. Substantially all the Company's operations, assets, and employees are in Canada. Revenue is earned in Canada and the United States. Its products are GEMS Sirona, GEMS WIN, Trident Pro 40L, HeartCheck CardiBeat - Mobile ECG Device, HeartCheck SMART Monitoring, and Others.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
EKGGF has been successfully added to your 
